Webinar for Notice of Special Interest (NOSI): Training Modules for Enhancing Biomedical Research Workforce Training
Notice Number:
NOT-GM-25-009

Key Dates

Release Date:

November 21, 2024

Related Announcements

November 22, 2023 - Modules for Enhancing Biomedical Research Workforce Training (R25 - Independent Clinical Trial Not Allowed). See NOFO PAR-24-040.

November 14, 2024 - Notice of Special Interest (NOSI): Topics for Training Modules for Enhancing Biomedical Research Workforce Training - 2025. See Notice NOT-GM-24-039.

Issued by

National Institute of General Medical Sciences (NIGMS)

Purpose

This Notice is to inform potential applicants that the National Institute of General Medical Sciences (NIGMS) will host an informational webinar to provide a program overview and respond to questions related to PAR-24-040 “Modules for Enhancing Biomedical Research Workforce Training (R25 - Independent Clinical Trial Not Allowed)."

Webinar Information

Date: Wednesday, December 4, 2024 

Time: 2:00-3:30 PM Eastern Standard Time

Please click this URL to join the meeting: https://nih.zoomgov.com/j/1605467748?pwd=ed6VrQb6Z8YY6xFDC1T8HyBddz4pOt.1

Meeting ID: 160 546 7748

Passcode: NIGMS

Or join by phone: 

Dial by your location

       +1 669 254 5252 US (San Jose)

       +1 646 828 7666 US (New York)

       +1 646 964 1167 US (US Spanish Line)

       +1 415 449 4000 US (US Spanish Line)

       +1 551 285 1373 US (New Jersey)

       +1 669 216 1590 US (San Jose)

Meeting ID: 160 546 7748

Passcode: 922050

Participation in the webinar, although encouraged, is optional and is not required for the submission of an application. Advanced registration is not required.

Note, this webinar will be recorded, and the content will be available for potential applicants on the Training Modules web page.

Participants requiring sign language interpretation and/or other reasonable accommodations should email [email protected] or call the Federal Relay Service at 800-877-8339 at least 5 days prior to the event.

Inquiries

Please direct all inquiries to the Scientific/Research Contacts listed in Part 2. Section VII. Agency Contacts in PAR-24-040.